The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures.
Keswani, Sanjay C
The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures. [electronic resource] - Journal of neuroscience methods Jul 2004 - 193-5 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0165-0270
10.1016/j.jneumeth.2004.01.004 doi
Animals
Animals, Newborn
Cell Culture Techniques--methods
Cells, Cultured
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical--methods
Fetus
GAP-43 Protein--genetics
Ganglia, Spinal--cytology
Gene Expression--drug effects
Nerve Degeneration--drug therapy
Neurons--cytology
Neuroprotective Agents--pharmacology
RNA, Messenger--analysis
Rats
Reproducibility of Results
Reverse Transcriptase Polymerase Chain Reaction--instrumentation
Tacrolimus--pharmacology
Zalcitabine--antagonists & inhibitors
The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures. [electronic resource] - Journal of neuroscience methods Jul 2004 - 193-5 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0165-0270
10.1016/j.jneumeth.2004.01.004 doi
Animals
Animals, Newborn
Cell Culture Techniques--methods
Cells, Cultured
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical--methods
Fetus
GAP-43 Protein--genetics
Ganglia, Spinal--cytology
Gene Expression--drug effects
Nerve Degeneration--drug therapy
Neurons--cytology
Neuroprotective Agents--pharmacology
RNA, Messenger--analysis
Rats
Reproducibility of Results
Reverse Transcriptase Polymerase Chain Reaction--instrumentation
Tacrolimus--pharmacology
Zalcitabine--antagonists & inhibitors